Tens of thousands of Americans have filed lawsuits alleging that glyphosate-based herbicides such as Roundup caused non-Hodgkin’s lymphoma. Those claims have already led to major verdicts, years of litigation, and a proposed $7.25 billion settlement from Bayer. But the fight has now moved well beyond individual courtrooms.

Chemical & Engineering News reports that more than 60,000 claims still threaten the future of glyphosate products in the United States.

Tens of thousands of Americans have filed glyphosate-related cancer lawsuits.

Federal Action Has Raised New Alarm

A February 2026 executive order pushed to support domestic production of glyphosate-based herbicides under the Defense Production Act. According to The New Lede, critics warned that the move could help provide “immunity” or other protection for manufacturers facing widespread cancer litigation.

Chemical & Engineering News similarly reported that the order could potentially shield manufacturers from liability tied to alleged health impacts and inadequate warning labels.

Many of those claims involve allegations of non-Hodgkin’s lymphoma.

Why The EPA And Agriculture Committees Matter

This is why the right targets matter. The EPA Administrator and the EPA Office of Chemical Safety and Pollution Prevention oversee the federal system that governs pesticide review and labeling. Meanwhile, the House Committee on Agriculture and the Senate Committee on Agriculture, Nutrition, and Forestry can shape Farm Bill language that affects pesticide policy and legal accountability.

A draft House farm bill included controversial provisions on pesticide labels and manufacturer liability, bringing the issue directly into congressional hands.

A new federal push has supported domestic glyphosate production.

Congress Has Already Seen A Pushback Effort

There has already been a legislative response. Quiver Quantitative reported that H.R. 7601, the No Immunity for Glyphosate Act, would block federal funds from implementing the executive order and would preserve a civil cause of action for people harmed by glyphosate exposure. That shows how serious the liability fight has become. It is no longer abstract. It is already moving through federal policy channels.

Families Should Not Lose Their Rights

Public debate over glyphosate’s health effects has not ended. One of the provided sources, Cancer.news, also points to concerns about possible immune-system effects, while the Lansing State Journal reflects the issue’s reach into farming communities and public debate.

When so many claims remain active, government should not make it harder for families to seek justice. The EPA and congressional agriculture committees must reject any policy that gives glyphosate manufacturers special protection from legitimate cancer lawsuits.

Click below to make a difference.